Pharmacogenomics of human ABC transporter ABCC11 (MRP8): Potential risk of breast cancer and chemotherapy failure

Anti-Cancer Agents in Medicinal Chemistry

Volumn 10, Issue 8, 2010, Pages 617-624

  Toyoda, Yu ^a   Ishikawa, Toshihisa ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Apocrine gland; Earwax; Estrogen receptor; Mastopathy; Multidrug resistance; Nucleoside; Single nucleotide polymorphism (SNP); Tamoxifen

Indexed keywords

ABC TRANSPORTER; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ESTRADIOL; FLUOROURACIL; FOLIC ACID; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

ABC TRANSPORTER GENE; APOCRINE GLAND; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHARMACOGENOMICS; PHENOTYPE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 79551646271     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152010794473975     Document Type: Review

References (54)

1. Weiss, S. T.; McLeod, H. L.; Flockhart, D. A.; Dolan, M. E.; Benowitz, N. L.; Johnson, J. A.; Ratain, M. J.; Giacomini, K. M. Creating and evaluating genetic tests predictive of drug response. Nat. Rev. Drug Discov. 2008, 7 (7), 568-574.
2. Sadee, W. Drug therapy and personalized health care: pharmacogenomics in perspective. Pharm. Res. 2008, 25 (12), 2713-2719.
3. Wilke, R. A.; Lin, D. W.; Roden, D. M.; Watkins, P. B.; Flockhart, D.; Zineh, I.; Giacomini, K. M.; Krauss, R. M. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat. Rev. Drug Discov. 2007, 6 (11), 904-916.
4. Andersson, T.; Flockhart, D. A.; Goldstein, D. B.; Huang, S. M.; Kroetz, D. L.; Milos, P. M.; Ratain, M. J.; Thummel, K. Drugmetabolizing enzymes: evidence for clinical utility of pharmacogenomic tests. Clin. Pharmacol. Ther. 2005, 78 (6), 559-581.
5. Kalow, W.; Meyer, U.; Tyndale, R. F. Pharmacogenomics. Marcel Dekker Inc.: New York, 2001.
6. Errasti-Murugarren, E.; Pastor-Anglada, M. Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics 2010, 11 (6), 809-841.
7. Cusatis, G.; Sparreboom, A. Pharmacogenomic importance of ABCG2. Pharmacogenomics 2008, 9 (8), 1005-1009.
8. Ishikawa, T.; Tsuji, A.; Inui, K.; Sai, Y.; Anzai, N.; Wada, M.; Endou, H.; Sumino, Y. The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 2004, 5 (1), 67-99.
9. Kim, R. B. Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances. Adv. Drug Deliv. Rev. 2002, 54 (10), 1241-1242.
10. Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; Hoffmaster, K. A.; Ishikawa, T.; Keppler, D.; Kim, R. B.; Lee, C. A.; Niemi, M.; Polli, J. W.; Sugiyama, Y.; Swaan, P. W.; Ware, J. A.; Wright, S. H.; Yee, S. W.; Zamek-Gliszczynski, M. J.; Zhang, L. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010, 9 (3), 215-236.
11. Holland, I.; Cole, S. P. C.; Kuchler, K.; Higgins, C. F. ABC Protein: From Bacteria to Man. Academic Press: Amsterdam 2002.
12. Borst, P.; Elferink, R. O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 2002, 71, 537-592.
13. Inoue, Y.; Mori, T.; Toyoda, Y.; Sakurai, A.; Ishikawa, T.; Mitani, Y.; Hayashizaki, Y.; Yoshimura, Y.; Kurahashi, H.; Sakai, Y. Correlation of axillary osmidrosis to a SNP in the ABCC11 gene determined by the Smart Amplification Process (SmartAmp) method. J. Plast. Reconstr. Aesthet. Surg. 2010, 63 (8), 1369-1374.
14. Toyoda, Y.; Sakurai, A.; Mitani, Y.; Nakashima, M.; Yoshiura, K.; Nakagawa, H.; Sakai, Y.; Ota, I.; Lezhava, A.; Hayashizaki, Y.; Niikawa, N.; Ishikawa, T. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J. 2009, 23 (6), 2001-2013.
15. Nakano, M.; Miwa, N.; Hirano, A.; Yoshiura, K.; Niikawa, N. A strong association of axillary osmidrosis with the wet earwax type determined by genotyping of the ABCC11 gene. BMC Genet. 2009, 10, 42.
16. Wang, B.; Miao, Z.; Liu, S.; Wang, J.; Zhou, S.; Han, L.; Meng, D.; Wang, Y.; Li, C.; Ma, X. Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum. Genet. 2010, 127 (2), 245-246.
17. Woodward, O. M.; Kottgen, A.; Coresh, J.; Boerwinkle, E.; Guggino, W. B.; Kottgen, M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl. Acad. Sci. USA, 2009, 106 (25), 10338-10342.
18. Matsuo, H.; Takada, T.; Ichida, K.; Nakamura, T.; Nakayama, A.; Ikebuchi, Y.; Ito, K.; Kusanagi, Y.; Chiba, T.; Tadokoro, S.; Takada, Y.; Oikawa, Y.; Inoue, H.; Suzuki, K.; Okada, R.; Nishiyama, J.; Domoto, H.; Watanabe, S.; Fujita, M.; Morimoto, Y.; Naito, M.; Nishio, K.; Hishida, A.; Wakai, K.; Asai, Y.; Niwa, K.; Kamakura, K.; Nonoyama, S.; Sakurai, Y.; Hosoya, T.; Kanai, Y.; Suzuki, H.; Hamajima, N.; Shinomiya, N. Common defects of ABCG2, a high-capacity urate exporter, cause gout: a functionbased genetic analysis in a Japanese population. Sci. Transl. Med. 2009, 1 (5), 5ra11.
19. Yabuuchi, H.; Shimizu, H.; Takayanagi, S.; Ishikawa, T. Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem. Biophys. Res. Commun. 2001, 288 (4), 933-939.
20. Tammur, J.; Prades, C.; Arnould, I.; Rzhetsky, A.; Hutchinson, A.; Adachi, M.; Schuetz, J. D.; Swoboda, K. J.; Ptacek, L. J.; Rosier, M.; Dean, M.; Allikmets, R. Two new genes from the human ATPbinding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001, 273 (1), 89-96.
21. Bera, T. K.; Lee, S.; Salvatore, G.; Lee, B.; Pastan, I. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol. Med. 2001, 7 (8), 509-516.
22. Shimizu, H.; Taniguchi, H.; Hippo, Y.; Hayashizaki, Y.; Aburatani, H.; Ishikawa, T. Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene 2003, 310, 17-28.
23. Bortfeld, M.; Rius, M.; Konig, J.; Herold-Mende, C.; Nies, A. T.; Keppler, D. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience 2006, 137 (4), 1247-1257.
24. Chen, Z. S.; Guo, Y.; Belinsky, M. G.; Kotova, E.; Kruh, G. D. Transport of bile acids, sulfated steroids, estradiol 17-beta-Dglucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol. Pharmacol. 2005, 67 (2), 545-557.
25. Bieche, I.; Girault, I.; Urbain, E.; Tozlu, S.; Lidereau, R. Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma. Breast Cancer Res. 2004, 6 (3), R252-263.
26. Park, S.; Shimizu, C.; Shimoyama, T.; Takeda, M.; Ando, M.; Kohno, T.; Katsumata, N.; Kang, Y. K.; Nishio, K.; Fujiwara, Y. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res. Treat. 2006, 99 (1), 9-17.
27. Honorat, M.; Mesnier, A.; Vendrell, J.; Guitton, J.; Bieche, I.; Lidereau, R.; Kruh, G. D.; Dumontet, C.; Cohen, P.; Payen, L. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifenresistant breast cancer cells. Endocr. Relat. Cancer 2008, 15 (1), 125-138.
28. Hauswald, S.; Duque-Afonso, J.; Wagner, M. M.; Schertl, F. M.; Lubbert, M.; Peschel, C.; Keller, U.; Licht, T. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. Clin. Cancer Res. 2009, 15 (11), 3705-3715.
29. Helenius, A.; Aebi, M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 2004, 73, 1019-1049.
30. Ellgaard, L.; Molinari, M.; Helenius, A. Setting the standards: quality control in the secretory pathway. Science 1999, 286 (5446), 1882-1888.
31. Kleizen, B.; Braakman, I. Protein folding and quality control in the endoplasmic reticulum. Curr. Opin. Cell Biol. 2004, 16 (4), 343-349.
32. Hampton, R. Y. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 2002, 14 (4), 476-482.
33. Ellgaard, L.; Helenius, A. ER quality control: towards an understanding at the molecular level. Curr. Opin. Cell Biol. 2001, 13 (4), 431-437.
34. Mori, K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000, 101 (5), 451-454.
35. Yoshiura, K.; Kinoshita, A.; Ishida, T.; Ninokata, A.; Ishikawa, T.; Kaname, T.; Bannai, M.; Tokunaga, K.; Sonoda, S.; Komaki, R.; Ihara, M.; Saenko, V. A.; Alipov, G. K.; Sekine, I.; Komatsu, K.; Takahashi, H.; Nakashima, M.; Sosonkina, N.; Mapendano, C. K.; Ghadami, M.; Nomura, M.; Liang, D. S.; Miwa, N.; Kim, D. K.; Garidkhuu, A.; Natsume, N.; Ohta, T.; Tomita, H.; Kaneko, A.; Kikuchi, M.; Russomando, G.; Hirayama, K.; Ishibashi, M.; Takahashi, A.; Saitou, N.; Murray, J. C.; Saito, S.; Nakamura, Y.; Niikawa, N. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat. Genet. 2006, 38 (3), 324-330.
36. Sakurai, A.; Onishi, Y.; Hirano, H.; Seigneuret, M.; Obanayama, K.; Kim, G.; Liew, E. L.; Sakaeda, T.; Yoshiura, K.; Niikawa, N.; Sakurai, M.; Ishikawa, T. Quantitative structure--activity relationship analysis and molecular dynamics simulation to functionally validate nonsynonymous polymorphisms of human ABC transporter ABCB1 (P-glycoprotein/MDR1). Biochemistry 2007, 46 (26), 7678-7693.
37. Shugyo, Y.; Sudo, N.; Kanai, K.; Yamashita, T.; Kumazawa, T.; Kanamura, S. Morphological differences between secretory cells of wet and dry types of human ceruminous glands. Am. J. Anat. 1988, 181 (4), 377-384.
38. Yoo, W. M.; Pae, N. S.; Lee, S. J.; Roh, T. S.; Chung, S.; Tark, K. C. Endoscopy-assisted ultrasonic surgical aspiration of axillary osmidrosis: a retrospective review of 896 consecutive patients from 1998 to 2004. J. Plast. Reconstr. Aesthet. Surg. 2006, 59 (9), 978-982.
39. Miura, K.; Yoshiura, K.; Miura, S.; Shimada, T.; Yamasaki, K.; Yoshida, A.; Nakayama, D.; Shibata, Y.; Niikawa, N.; Masuzaki, H. A strong association between human earwax-type and apocrine colostrum secretion from the mammary gland. Hum. Genet. 2007, 121 (5), 631-633.
40. Gesase, A. P.; Satoh, Y. Apocrine secretory mechanism: recent findings and unresolved problems. Histol. Histopathol. 2003, 18 (2), 597-608.
41. Shehadeh, N. H.; Kligman, A. M. The effect of topical antibacterial agents on the bacterial flora of the axilla. J. Invest. Dermatol. 1963, 40, 61-71.
42. Julesz, M. New advances in the field of androgenic steroidogenesis of the human skin. Acta Med. Acad. Sci. Hung. 1968, 25 (3), 273-285.
43. Brooksbank, B. W. Labelling of steroids in axillary sweat after administration of 3H-delta-5-pregnenolone and 14C-progesterone to a healthy man. Experientia 1970, 26 (9), 1012-1014.
44. Labows, J. N.; Preti, G.; Hoelzle, E.; Leyden, J.; Kligman, A. Steroid analysis of human apocrine secretion. Steroids 1979, 34 (3), 249-258.
45. Petrakis, N. L. Cerumen genetics and human breast cancer. Science 1971, 173 (994), 347-349.
46. Ing, R.; Petrakis, L.; Ho, H. C. Evidence against association between wet cerumen and breast cancer. Lancet 1973, 1 (7793), 41.
47. Ota, I.; Sakurai, A.; Toyoda, Y.; Morita, A.; Sasaki, T.; Chishima, T.; Yamakado, M.; Kawai, Y.; Ishidao, T.; Lezhava, A.; Yoshiura, K.; Yogo, S.; Hayashizaki, Y.; Ishikawa, T.; Ishikawa, T.; Endo, I.; Ishimada, H. Association Between Breast Cancer Risk and the Wild-Type Allele of Human ABC Transporter ABCC11. Anticancer Res. 2011, 30(12), 5189-5194.
48. Oguri, T.; Bessho, Y.; Achiwa, H.; Ozasa, H.; Maeno, K.; Maeda, H.; Sato, S.; Ueda, R. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol. Cancer Ther. 2007, 6 (1), 122-127.
49. Kruh, G. D.; Guo, Y.; Hopper-Borge, E.; Belinsky, M. G.; Chen, Z. S. ABCC10, ABCC11, and ABCC12. Pflugers. Arch. 2007, 453 (5), 675-684.
50. Guo, Y.; Kotova, E.; Chen, Z. S.; Lee, K.; Hopper-Borge, E.; Belinsky, M. G.; Kruh, G. D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. J. Biol. Chem. 2003, 278 (32), 29509-29514.
51. Abbruzzese, J. L.; Grunewald, R.; Weeks, E. A.; Gravel, D.; Adams, T.; Nowak, B.; Mineishi, S.; Tarassoff, P.; Satterlee, W.; Raber, M. N.; Plunkett, W. A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J. Clin. Oncol. 1991, 9 (3), 491-498.
52. Heinemann, V.; Hertel, L. W.; Grindey, G. B.; Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1988, 48 (14), 4024-4031.
53. Guo, Y.; Kock, K.; Ritter, C. A.; Chen, Z. S.; Grube, M.; Jedlitschky, G.; Illmer, T.; Ayres, M.; Beck, J. F.; Siegmund, W.; Ehninger, G.; Gandhi, V.; Kroemer, H. K.; Kruh, G. D.; Schaich, M. Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival. Clin. Cancer Res. 2009, 15 (5), 1762-1769.
54. Uemura, T.; Oguri, T.; Ozasa, H.; Takakuwa, O.; Miyazaki, M.; Maeno, K.; Sato, S.; Ueda, R. ABCC11/MRP8 confers pemetrexed resistance in lung cancer. Cancer Sci. 2010, 101(11), 2404-2410.